Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Recurrent Glioblastoma Multiforme
NCT00099060Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2004
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of lapatinib in glioblastoma multiforme (GBM), sponsored by National Cancer Institute. Started Dec 2004; status: completed.
02
Drugs
lapatinib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00099060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099060.